Most users perceive marijuana as a healthy, natural plant. It's touted as a cure or treatment for pain, anxiety, seizures, and other various ailments. Yet, much of this is false. Dr. Roneet Lev, a board-certified emergency medicine physician and addiction specialist, tells us about what the pot industry prefers to keep to itself.

To view article click here.

IPS and the Center for Community Research, along with the district attorney’s office and the Behavioral Health Services Department in San Diego County’s Health and Human Services Agency, are joining forces to raise awareness about poly-drug use and driving. The innovative campaign focuses on sensible upstream prevention methods to reduce poly-drug use, increase driver education and promote responsible decisions like the use of ridesharing.

To view full article click here.

Now, consider the exposure of those 6.7 million consumers – and the untold number of cannabis-curious Californians – to Big Cannabis’ battery of attention-grabbing advertisements, such as eye-catching billboards, slick magazine advertisements and provocative digital ads. Think of the consumers, on the receiving end of this advertising onslaught, absorbing the industry’s alluring product-pushing messages without the benefit of counterbalancing them with health warnings about safer-use information.

To view OPED click here.

Delta-8 tetrahydrocannabinol, also known as delta-8 THC, is a psychoactive substance found in the Cannabis sativa plant, of which marijuana and hemp are two varieties. Delta-8 THC is one of over 100 cannabinoids produced naturally by the cannabis plant but is not found in significant amounts in the cannabis plant. As a result, concentrated amounts of delta-8 THC are typically manufactured from hemp-derived cannabidiol (CBD).

Click here for more on Delta-8 THC.

Today, the U.S. Food and Drug Administration issued warning letters to five companies for selling products labeled as containing delta-8 tetrahydrocannabinol (delta-8 THC) in ways that violate the Federal Food, Drug, and Cosmetic Act (FD&C Act). This action is the first time the FDA has issued warning letters for products containing delta-8 THC. Delta-8 THC has psychoactive and intoxicating effects and may be dangerous to consumers. The FDA has received reports of adverse events experienced by patients who have consumed these products.

To see FDA news release click here.